Andrew Cothrel brings a unique set of skills to medtech and lifesciences businesses ranging from start-ups to Fortune 500s. After a successful corporate career starting on the “product” side of the business and ending with a VP/general management role, in 2007 he founded Blue Marble Medical to address the growing demand for a single source providing a wide range of expertise in lifesciences. Andrew provides guidance across many areas of medtech/lifesciences business, from research and development to operations optmization to capital formation and go-to-market strategy. Past projects span health IT, in-vitro diagnostics, orthopedics, critical care, cardiovascular devices, and life science research tools, as well as cleantech . With each client project, Andrew plays an active role, leveraging his extensive network and working closely with the company to successfully reach its goals. As Blue Marble Medical has evolved, it has continued to customize its services for each client’s specific needs. Whether it be for an investor, an entrepreneur, a Fortune 500 or a hospital, Blue Marble Medical will provide the analysis, focus and solutions for success.
- Melanie DeFord – Sr. Director for Strategic Research Programs & Resources, University of Notre Dame
- Diana Caldwell – Co-Founder, President and CEO, Pearl Pathways